Skip to main content
ConductScienceScienceDex

Andrew James Aguirre

FY2026 NIH rank #9,889
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10995625Search this ID in NIH RePORTER
ORCID iD
https://orcid.org/0000-0002-0701-6203Verified identifier for this researcher
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2026

Linked Award Amount
$2.1M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#9,889
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Andrew James Aguirre. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NCI

National Cancer Institute

$2.1M

3 awards · administering

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Andrew James Aguirre as a PI. Multi-PI records show the full award amount for context.

  • 5U01CA274276-05U01
    Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity
    Dana-Farber Cancer Institute
    $1M
    award amount
  • 5R01CA276268-04R01
    Mechanisms of response and resistance to KRAS inhibition in pancreatic cancer
    Dana-Farber Cancer Institute
    $561.8K
    award amount
  • 5R01CA233626-07R01
    The function of the PRMT5 methylosome in MTAP deleted cancers
    Broad Institute, Inc.
    $453.4K
    award amount

Award organizations

Organizations that administered FY2026 awards listing Andrew James Aguirre as a PI.

Dana-Farber Cancer Institute
MA
$1.6M
2 grants
Broad Institute, Inc.
MA
$453.4K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Dana-Farber Cancer Institute
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #8416
  5. 2025
    $2M Cumulative Funding
  6. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  7. 2025
    R01 Grant Holder
  8. 2025
    Program/Center Grant Leader
  9. 2026
    $5M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Andrew James Aguirre.

Stephanie Dougan
Dana-Farber Cancer Institute
3
shared awards
William C. Hahn
Dana-Farber Cancer Institute
3
shared awards
William R Sellers
Broad Institute, Inc.
2
shared awards

Explore further

Find collaborators for Andrew James Aguirre

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →